Imagion Biosystems secures AU$3.75M following FDA clearance for Phase 2 clinical trial of MagSense® imaging in HER2+ breast cancer.
Amount Raised
A$3.75 Million
Round Type
Post-IPO Equity
MelbourneBiotechnologyHealth CareMedicalMedical DeviceTherapeuticsHealth DiagnosticsInvestors
Description
Imagion Biosystems has raised AU$3.75M to fund the commencement of a Phase 2 clinical trial for its MagSense® imaging agent. The funding follows the FDA's clearance of their IND application. The raise was led by CPS Capital Group Pty Ltd. Patient recruitment for the trial is expected to begin later this year.
Quick answer
Imagion Biosystems raised A$3.75 Million in a Post-IPO Equity round, dated June 25, 2026. Investors: CPS Capital Group Pty Ltd. Imagion Biosystems is based in Melbourne, Victoria, Australia.
- How much did Imagion Biosystems raise?
- Imagion Biosystems raised A$3.75 Million in a Post-IPO Equity round on June 25, 2026.
- Who invested in Imagion Biosystems?
- CPS Capital Group Pty Ltd is named as investors in this round.
- What does Imagion Biosystems do?
- Imagion Biosystems is a clinical-stage imaging company pioneering a new category of MRI technology that changes suspicion into certainty.
- Where is Imagion Biosystems based and how big is it?
- Imagion Biosystems is based in Melbourne, Victoria, Australia. Fundz records about 11 employees.
- Who are the decision-makers at Imagion Biosystems?
- Fundz holds 1 contact at Imagion Biosystems, including the President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Imagion Biosystems that raised within 45 days of this round, from Fundz verified event records.
- Vexev raised $6M on August 6, 2026.
- Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
- TidalSense raised $19M on July 24, 2026.
- Neuble AI raised $269K (Seed) on July 16, 2026.
- Respiro Diagnostics raised $1.3M (Pre-Seed) on July 8, 2026.
- Grail raised $110M (Post-IPO Equity) on June 25, 2026.
Who to call at Imagion Biosystems, and when
A new round usually means Imagion Biosystems is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Imagion Biosystems raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Imagion Biosystems, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Imagion Biosystems. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Imagion Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Imagion Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.